top of page
Latest news


Meet CONNECT's newest partner
We are delighted to welcome our newest partner, Daiichi Sankyo. "We joined CONNECT to collaborate with the key actors who can accelerate access to innovative therapies," said Martin Ahlgren, Medical Director Nordics. Through their CONNECT partnership, Daiichi Sankyo aims to deepen engagement with clinical investigators, create new opportunities for clinical studies, and help strengthen the Nordic precision-oncology infrastructure. This alignment is crucial for Daiichi Sankyo,
Nov 171 min read


CONNECT at Arendalsuka 2025
CONNECT marked its fifth anniversary during Arendalsuka 2025 with a seminar explaining how collaboration between industry, public...
Aug 252 min read


CONNECT expands with new partner
Kristie van Lieshout, Market Access & Healthcare Affairs Manager, Boehringer Ingelheim Norway ”Being part of the CONNECT Consortium...
May 132 min read
Connect Academy #4 – Ny nasjonal Kreftstrategi – hva betyr denne for presisjonskreftmedisinen
Den 28. april, 15.30-17.00 inviterer til enda et Connect Academy. Denne gangen inviterer vi til et fysisk møte på nye Radiumhospitalet. I...
May 21 min read
Connect Academy #3 – Erfaringer med sertifisering til CCC. Status og videre prosess.
Den 11. april, 14.00-15.00 invitererte vi til årets tredje Connect Academy, hvor temaet er arbeidet som gjøres med sertifisering for CCC...
Apr 141 min read
Clinical Trials and choice of study sites. Norway seen from the outside
On 11 March 2024, the CONNECT Academy webinar meeting series was held online. The topic of this webinar was " Clinical Trials and choice...
Mar 111 min read
Precision Medicine in Gynecological Cancer
The topic of this webinar was "Precision Medicine in Gynecological Cancer - From professional consensus to implementation".
Feb 41 min read


Digital pathology and AI
Watch the CONNECT Academy webinar Digital Pathology and AI here.
Sep 25, 20241 min read


Personalised medicine: a political priority
Precision cancer medicine is challenging politicians, health authorities, industry and patient organisations to think new about current meth
Aug 16, 20243 min read
bottom of page
